Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Resveratrol, curcumin
Atrium Therapeutics
Effect of Resveratrol and Curcumin on Inflammation
1 trial -
Ringer's solution acetate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cholecystolithiasis and Thyroid Nodule
1 trial -
Rituximab, Methotrexate, and Thiotepa (R-MT) Induction Followed by Etoposide and Cytarabine (EA) Consolidation
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma (PCNSL)
1 trial -
Ropivacaine
Lei Xiaoming
Cystic Adenomatoid Malformation of Lung, Congenital
1 trial -
Routine IOP-lowering medications
Zhongshan Ophthalmic Center, Sun Yat-sen University
Open Angle Glaucoma
1 trial -
Routine Medication
The First People's Hospital of Lianyungang
Generalized Anxiety Disorder
1 trial -
Rozerem
Takeda
REM Behavior Disorder
1 trial -
S-ketamine
Nanjing Zenshine Pharmaceuticals
Opioid Use, Unspecified
1 trial -
S-ketamine
The First People's Hospital of Lianyungang
Opioid Use, Unspecified
1 trial -
SGLT2 inhibitor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Kidney Transplantation
1 trial -
SSRI treated group
Samsung Bioepis NL B.V.
Depression
2 trials -
Sana Device (Control)
Sana Biotechnology
Fibromyalgia
1 trial -
Sapropterin
BioMarin Pharmaceutical Australia Pty Ltd
Hyperphenylalaninemia
1 trial -
Sarcosine
BRIGHT MINDS BIOSCIENCES INC.
Schizophrenia
1 trial -
Saturated fat
United Therapeutics Europe Ltd
Cardiovascular Disease
1 trial -
Seasonal malaria chemoprevention
United Therapeutics Europe Ltd
Malaria
1 trial -
Semaglutide
GT Biopharma
Obesity (Disorder)
1 trial -
Seromycin (D-cycloserine, DCS)
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Addiction
1 trial -
Sevoflurane
The First People's Hospital of Lianyungang
Liver Transplantation
1 trial -
Short course palliative radiation.
Hospital Authority, Hong Kong
Cervical Cancer
1 trial -
Single dose of 2L PEG
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Health Behavior
1 trial -
Single dose of ibuprofen (800 mg tablet)
BRIGHT MINDS BIOSCIENCES INC.
Human Gastrointestinal Physiology Data
1 trial -
Sitz-Markers
United Therapeutics Europe Ltd
Return of Bowel Function After Colon Surgery
1 trial -
Sivelestat
The First People's Hospital of Lianyungang
Aortic Dissection
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources